Comparison

IQVIA Scribe vs MyStudyManager

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

IQVIA Scribe

This application allows patients participating in clinical trials to securely capture and submit data directly from their mobile devices. It provides relevant questionnaires throughout the study duration, amplifying patient voices in research.

Highlights
  • Online/offline data capture
  • Patient enrollment notifications
  • Study-specific questionnaires
  • Secure data submission
  • Automated eCOA process
Features
Read full description

IQVIA Scribe is an online/offline application used to capture data directly from patients enrolled in clinical trials. Patients enrolled in a study using Scribe will receive an enrollment notification via email or text with a link to download the application and instructions used to enroll in the study. Relevant questionnaires will be available for completion throughout the duration of the study ++++Scribe amplifies the patient's voice in clinical research by allowing Clinical Outcomes Assessments to be used in more trials. Whether deploying to smartphones, tablets or the web, our Sculptor visual build and deployment tools help automate the eCOA process, giving absolute transparency and greater control to sponsors and CRO’s.

About

MyStudyManager

Features
Read full description

MyStudyManager™ Participant Portal provides convenient tools to make study participation easier while allowing researchers to improve recruitment, compliance, and retention in, both, traditional ‘in-clinic’ trials and/or Decentralized Clinical Trial (DCT) environments. With this technology, participants can now carry their studies on-the-go, creating more connection, access and opportunity in clinical research while vastly improving the participation experience. Key features include study participant access to Calendar Events and Scheduling, Study Consents via eCONSENT, Important Study Notifications, Stipend Payments, Video Conferencing/Remote Visits, Site Contact Information, Participant Questionnaire/ePROs, and more.

Screenshots

IQVIA Scribe3 screens
MyStudyManager4 screens

Verdict

The call

The clearest difference is update cadence: IQVIA Scribe at every 2 months against MyStudyManager's every 5 months. On price, ads, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

IQVIA Scribe ships an update every 2 months, MyStudyManager every 5 months. The most recent releases landed on November 1, 2026 and October 27, 2026 respectively.

Scorecard1 real difference · 9 level
IQVIA Scribe versus MyStudyManager: the parameters behind the verdict, then further details
ParameterIQVIA ScribeMyStudyManager
PriceFreeFree
Rating2.9 (38 ratings) — better—
Positive reviews19.0% of reviews—
Number of ratings38 — better—
Update frequencyEvery 2 months — betterEvery 5 months
AdsNoNo
In-app purchasesNoNo
MonetizationFree—
DevicesiPhone, iPad, iPod — betteriPhone, iPad
Requires iOS15.5 — better16.6
Further details — not scored
Size33 MB59 MB
Age rating4+4+
DeveloperIQVIA RDS INC.RealTime Software Solutions

In-app purchases

None

IQVIA Scribe

No in-app purchases

None

MyStudyManager

No in-app purchases

Questions

Is IQVIA Scribe free?
IQVIA Scribe is free to download, with no in-app purchases.
Is MyStudyManager free?
MyStudyManager is free to download, with no in-app purchases.
Do IQVIA Scribe or MyStudyManager have ads?
Neither IQVIA Scribe nor MyStudyManager shows ads.
Which is updated more often, IQVIA Scribe or MyStudyManager?
IQVIA Scribe ships an update every 2 months, and MyStudyManager every 5 months. Most recently, IQVIA Scribe was updated on November 1, 2026 and MyStudyManager on October 27, 2026.

Other comparisons